NFKB1缺失导致小鼠胃内肿瘤坏死因子表达及信号转导和转录激活因子1激活从而促进胃肿瘤发生
研究通过将Nfkb1-/-小鼠与Il6-/-、Il22-/-、Il11Rα-/-及Tnf-/-小鼠杂交,分析胃组织,发现NFKB1缺失引起胃内TNF表达增加并激活STAT1,驱动炎症免疫反应和胃癌发生;IL11R似乎为胃肿瘤进展至浸润期所必需。作者认为TNF抑制剂及可能的IL11/IL11Rα抑制剂或可用于胃癌治疗。
要点
- Nfkb1-/-小鼠发生胃炎、泌酸腺萎缩、胃异型增生和浸润性肿瘤,而Nfkb1-/-Stat1-/-小鼠即使观察长达2年也未发生。
- Nfkb1-/-Tnf-/-小鼠较Nfkb1-/-小鼠胃炎和泌酸腺萎缩显著减轻、肿瘤减少,伴STAT1和STAT3活化降低及胃体T细胞和B细胞浸润减少。
- STAT1或TNF缺失显著降低Nfkb1-/-小鼠胃黏膜上皮和髓系(CD11b+)细胞PD-L1表达,降至野生型对应细胞水平。
核心结论
- 在小鼠敲除模型中发现,NFKB1缺失导致胃内TNF表达增加,进而驱动STAT1激活,引起炎症免疫反应和胃癌发生。
- IL11R似乎为胃肿瘤进展至浸润期所必需。
- 作者认为TNF抑制剂及可能的IL11/IL11Rα抑制剂或可用于胃癌治疗。
研究设计与样本
- 将Nfkb1-/-小鼠与Il6-/-、Il22-/-、Il11Rα-/-和Tnf-/-小鼠杂交,对复合突变小鼠胃组织进行组织学、免疫印迹和RNA测序分析,并分离胃内淋巴、髓系和上皮细胞用流式细胞术检测细胞因子水平。
主要发现
- Nfkb1-/-小鼠发生胃炎、泌酸腺萎缩、胃异型增生和浸润性肿瘤,而Nfkb1-/-Stat1-/-小鼠未发生,即使观察长达2年。
- Nfkb1-/-小鼠胃体和胃窦的Il6、Il11、Il22和Tnf信使RNA水平从3-6月龄起升高。
- Nfkb1-/-Il6-/-、Nfkb1-/-Il22-/-和Nfkb1-/-Il11Rα-/-小鼠仍发生胃肿瘤,但IL11受体缺失显著减少浸润性胃肿瘤的发生。
- Nfkb1-/-Tnf-/-小鼠较Nfkb1-/-小鼠胃炎和泌酸腺萎缩显著减轻、肿瘤减少,伴STAT1和STAT3活化降低及胃体T细胞和B细胞浸润减少。
- STAT1或TNF缺失显著降低Nfkb1-/-小鼠胃黏膜上皮和髓系(CD11b+)细胞PD-L1表达,降至野生型对应细胞水平。
临床怎么用
- 作者认为TNF抑制剂及可能的IL11/IL11Rα抑制剂或可用于胃癌治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Activity of nuclear factor κB transcription factors and signaling via signal transducer and activator of transcription (STAT) are frequently altered in gastric cancer cells. Mice lacking NFKB1 (Nfkb1-/- mice) develop invasive gastric cancer, and their gastric tissues have increased levels of cytokines, such as interleukin (IL) 6, IL22, IL11, and tumor necrosis factor (TNF), as well as increased activation of STAT1. We investigated whether these cytokines were required for STAT1 activation in gastric tissues of mice and critical for gastric tumorigenesis. METHODS: We crossed Nfkb1-/- mice with Il6-/-, Il22-/-, Il11Rα-/-, and Tnf-/- mice. Stomach tissues from compound mutant mice were analyzed by histology, immunoblotting, and RNA sequencing. Lymphoid, myeloid, and epithelial cells were isolated from stomachs, and the levels of cytokines were determined by flow cytometric analysis. RESULTS: Nfkb1-/- mice developed gastritis, oxyntic atrophy, gastric dysplasia, and invasive tumors, whereas Nfkb1-/-Stat1-/- mice did not, even when followed for as long as 2 years. The levels of Il6, Il11, Il22, and Tnf messenger RNA were increased in the body and antrum of the stomachs from Nfkb1-/- mice, from 3-6 months of age. However, Nfkb1-/-Il6-/-, Nfkb1-/-Il22-/-, and Nfkb1-/-Il11Rα-/- mice still developed gastric tumors, although the absence of IL11 receptor (IL11R) significantly reduced development of invasive gastric tumors. Stomachs from Nfkb1-/-Tnf-/- mice exhibited significantly less gastritis and oxyntic atrophy and fewer tumors than Nfkb1-/- mice. This correlated with reduced activation of STAT1 and STAT3 and fewer numbers of T cells and B cells infiltrating the gastric body. Loss of STAT1 or TNF significantly reduced expression of PD-L1 on epithelial and myeloid (CD11b+) cells in the gastric mucosa of Nfkb1-/- mice-indeed, to the levels observed on the corresponding cells from wild-type mice. CONCLUSIONS: In studies of gastric tumor development in knockout mice, we found that loss of NFKB1 causes increased expression of TNF in the stomach and thereby drives activation of STAT1, resulting in an inflammatory immune response and the development of gastric cancer. IL11R appears to be required for the progression of gastric tumors to the invasive stage. These findings suggest that inhibitors of TNF, and possibly also inhibitors of IL11/IL11Rα, might be useful in the treatment of gastric cancer.
引用
- Low JT, Christie M, Ernst M, et al. Loss of NFKB1 Results in Expression of Tumor Necrosis Factor and Activation of Signal Transducer and Activator of Transcription 1 to Promote Gastric Tumorigenesis in Mice. Gastroenterology. 2020. PMID: 32569771. doi:10.1053/j.gastro.2020.06.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。